Breaking News

ACA coverage losses in the One Big Beautiful Bill

May 30, 2025
Summit is led by billionaire co-CEO Bob Duggan.
Wikimedia Commons

STAT+ | Summit shows mixed results from key study of lung cancer drug

Ivonescimab, which had been previously tested in China, has been closely tracked for its blockbuster potential.

By Adam Feuerstein


STAT+ | ACA reforms in the GOP's tax bill were little-noticed. That might change

Little noticed, the ACA reforms in the tax bill could lower enrollment about as much as Medicaid cuts will, and in many of the same states Trump won.

By John Wilkerson


25 million cavities and $9.8 billion: Study estimates the costs of removing fluoride from water

Study warns national water fluoridation ban could cause 25 million cavities, cost $9.8 billion, as RFK Jr. renews debate on health risks

By Anil Oza



Adobe

STAT+ | Medicare plots ambitious tech agenda guided by former Palantir, Main Street Health executives

Medicare wants a tech upgrade to address difficulties patients face in accessing care, and stimulate innovations across industry.

By Mario Aguilar


STAT+ | Next-gen COPD drug from Sanofi, Regeneron shows mixed results in Phase 3 trials

The drug led to a reduction in exacerbations in one study, but missed the mark in another. The companies said they are reviewing the data.

By Andrew Joseph


STAT+ | Solicitor general urges Supreme Court not to review an Oklahoma law for regulating PBMs

The U.S. solicitor general agreed with the appeals court on three provisions of the state law that the PBM trade group had challenged.

By Ed Silverman


HHS Secretary Robert F. Kennedy Jr. speaks as Education Secretary Linda McMahon listens during a Make America Healthy Again Commission event in the East Room of the White House last week in Washington.
Jacquelyn Martin/AP

White House acknowledges problems in RFK Jr.'s MAHA report

The White House will fix errors in the much-anticipated report, which decried America's food supply, pesticides, and prescription drugs.

By Associated Press


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments